Star Imaging and Path Lab Ltd
Incorporated in 2004, Star Imaging and Path Lab Limited is a healthcare company providing diagnostic services across a wide range of medical tests.[1]
- Market Cap ₹ 145 Cr.
- Current Price ₹ 83.1
- High / Low ₹ 152 / 46.0
- Stock P/E 7.31
- Book Value ₹ 61.3
- Dividend Yield 0.00 %
- ROCE 33.7 %
- ROE 40.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.8%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 227 days.
- Working capital days have increased from 45.0 days to 124 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of BSE SME IPO
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 69 | 58 | 78 | 82 | |
| 54 | 52 | 56 | 53 | |
| Operating Profit | 15 | 6 | 23 | 29 |
| OPM % | 21% | 10% | 29% | 35% |
| 0 | 0 | 1 | 0 | |
| Interest | 2 | 2 | 2 | 3 |
| Depreciation | 4 | 3 | 5 | 5 |
| Profit before tax | 9 | 1 | 16 | 21 |
| Tax % | 33% | 34% | 23% | 25% |
| 6 | 1 | 12 | 16 | |
| EPS in Rs | 42.00 | 3.80 | 82.27 | 11.79 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 6% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 36% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 34% |
| Last Year: | 41% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 14 | 17 |
| Reserves | 17 | 17 | 30 | 34 | 89 |
| 30 | 27 | 31 | 33 | 20 | |
| 10 | 16 | 19 | 18 | 22 | |
| Total Liabilities | 58 | 61 | 81 | 98 | 150 |
| 15 | 19 | 22 | 21 | 26 | |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 43 | 42 | 60 | 77 | 124 | |
| Total Assets | 58 | 61 | 81 | 98 | 150 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 14 | 6 | 18 | -6 | |
| -4 | -9 | -7 | -4 | |
| -7 | -5 | 2 | -0 | |
| Net Cash Flow | 3 | -7 | 13 | -10 |
| Free Cash Flow | 10 | -2 | 11 | -10 |
| CFO/OP | 115% | 115% | 98% | -2% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 86 | 110 | 151 | 227 |
| Inventory Days | ||||
| Days Payable | ||||
| Cash Conversion Cycle | 86 | 110 | 151 | 227 |
| Working Capital Days | 6 | -12 | 23 | 124 |
| ROCE % | 6% | 33% | 34% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|
| CT Scan Machines Infrastructure Number |
|
||
| MRI Machines Infrastructure Number |
|||
| Number of PPP Centers Number |
|||
| Pathology Tests Number of Tests |
|||
| Radiology Tests - CT Scan Number of Tests |
|||
| Radiology Tests - MRI Number of Tests |
|||
| Radiology Tests - X-Ray Number of Tests |
|||
| Total Diagnostic Centers Number |
|||
Extracted by Screener AI
Documents
Announcements
-
Clarification On Price Movement Of Share
10 Apr - Company clarified recent share price movement was market-driven, with no undisclosed material information.
-
Clarification sought from Star Imaging And Path Lab Ltd
10 Apr - Exchange has sought clarification from Star Imaging And Path Lab Ltd on April 9, 2026 with reference to significant movement in price, in order to …
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 -Opening Of New Diagnostic Centre At Dwarka, New Delhi
9 Apr - Lease executed for new Dwarka diagnostic centre; ₹14 crore capex, expected commencement 1 August 2026.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
9 Apr - Compliance certificate under Regulation 74(5) for quarter ended 31 March 2026 filed.
- Closure of Trading Window 27 Mar
Business Profile[1]
Star Imaging and Path Lab Limited (originally Janta X-Ray Clinic) is a Delhi-based diagnostic healthcare service provider offering pathology, radiology, cardiology, and neurology services. The company operates through B2C, B2B, and B2G models, with NABL-accredited facilities.